-

CITRIX SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Class Action Against Citrix Systems, Inc. (CTXS)  

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased Citrix Systems, Inc. (NASDAQ: CTXS) securities between January 22, 2020 and October 6, 2021. Citrix is a software company that provides users with secure remote access to computer networks.

If you suffered a loss due to Citrix Systems, Inc.'s misconduct, click here.

Citrix Systems, Inc. (CTXS) Misled Investors Regarding Subscriber Interest in its Cloud-Based Service

According to the complaint, in 2019, Citrix announced it would be shifting from a perpetual license model to a subscription license payment model, as well as transitioning from a software solution previously provided on-premises to a cloud-based service. During the class period, the Company claimed that the transition to a cloud-based product and to a subscription-pricing model was going smoothly and successfully.

Then, on April 29, 2021, Citrix announced lower than expected license conversions and that customers were not transitioning to the long-term cloud contracts as expected. On this news, the stock price fell 7.6%. However, the Company continued to assure investors that this was a "very isolated item" and that the "transition to the cloud is progressing well."

On July 29, 2021, Citrix reported that, despite prior assurances, the transition to the cloud was not as successful as the Company had led investors to believe. Citrix also announced a major restructuring of its sales leadership in order to "enhance [its] focus on" cloud migration. These changes were "significant and may cause short-term disruption before yielding tangible results." Following these disclosures, Citrix's stock dropped from $114.55 to $99.00 per share, or 13.6%.

Finally, on October 6, 2021, Citrix announced that its president and chief executive officer had stepped down. On this news, the Company's stock dropped from $105.96 to $98.32 per share over the next two days.

If you purchased shares of Citrix Systems, Inc. (CTXS) securities between January 22, 2020 and October 6, 2021, you have until January 18, 2022, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Citrix Systems, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Erasca, Inc. Class Action Reminder - Robbins LLP Encourages ERAS Stockholders to Contact the Firm for Information About Their Rights  

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call...

ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information About the Class Action Against ADMA Biologics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ: ADMA) securities between August 9, 2024 and March 25, 2026. ADMA Biologics, Inc. is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. For more information...

VIA Transportation, Inc. Stock Drop: Harmed Investors Should Contact Robbins LLP for Information About Leading the Class Action Against VIA

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Via Transportation, Inc. (NYSE: VIA) in connection with the Company's September 15, 2025 initial public statement ("IPO"). Via Transportation, Inc. provides a platform that transforms global transportation systems into digital networks in the United States, Germany, and internationally.For more information, submit a form, email attorney Aaron D...
Back to Newsroom